Who
Daniel Rabinowitz
Sec. and Chief Legal Officer
Company insider
Files Form 4 as: Sec. and Chief Legal Officer, Natera.
In numbers
- Trades disclosed
- 313
- Buys
- 0
- Sells
- 82
- Bought
- $0
- Sold
- $69.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Jun 2021
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $90K334 at $267.99 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $90K334 at $267.99 | filing |
| 28 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $255K1,003 at $254.07 | filing |
| 28 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $255K1,003 at $254.07 | filing |
| 27 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $230K884 at $260.49 | filing |
| 27 Jul 2026filed 29 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $230K884 at $260.49 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $418K1,568 at $266.79 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $567K2,045 at $277.29 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $544K1,955 at $278.25 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $84K300 at $278.77 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $993K3,705 at $268.11 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $520K1,932 at $268.99 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $131K484 at $269.87 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $368K1,357 at $270.96 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $124K454 at $272.14 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $137K500 at $274.19 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $303K1,100 at $275.20 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $387K1,400 at $276.24 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $418K1,568 at $266.79 | filing |
| 1 Jul 2026filed 6 Jul 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $993K3,705 at $268.11 | filing |
News
Financial Comparison: Valneva (NASDAQ:VALN) and Natera (NASDAQ:NTRA)NTRA · tickerreport.com · 22 Oct 2026Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?NTRA · insidermonkey.com · 20 Oct 2026ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology | wallstreetONLINENTRA · wallstreet-online.de · 19 Oct 2026
0 headlines in the last 90 days name Daniel Rabinowitz; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.